Department of Bioengineering and Therapeutic Sciences

Major Mexican genetic study uncovers basis for health differences among Latinos

The most comprehensive genetic study of the Mexican population to date has revealed as much genetic differentiation as the variation between some Europeans and Asians.

FDA launches UCSF-Stanford center for innovation in drug development, regulation

The U.S. Food and Drug Administration (FDA) is tapping the UCSF School of Pharmacy and Stanford University to launch its first West Coast regulatory science center, focused on spurring innovation in the development and evaluation of safer and more effective medications.

Update from the Dean - Spring/Summer 2014

Survey results; Strategic planning, retreat results and education; Recently received research funding (Szoka, Wells, Bandyopadhyay); Recent faculty publications (Kortemme, Renslo and Arkin, Van Osdol and Tsourounis); SB 493: Pharmacist provider status legislation; Walgreens at UCSF; Safeway...

Sourav Bandyopadhyay, PhD

Professor

I seek to understand, at the systems level, how biological networks within cancer cells are fundamentally different from those in normal cells. Using a variety of experimental techniques, I design new platforms for the rational application of personalized medicine and the design of combination...

Fraser named Searle Scholar, will shine new light on protein shapeshifting

Biophysicist James Fraser, PhD, has been named a 2014 Searle Scholar. His laboratory will be awarded $300,000 in funding over the next three years to support his research into more accurately and precisely describing the ways that protein molecules change shape to carry out the functions of life in...

UCSF School of Pharmacy leads in NIH funding for 34th year in a row

For the 34th consecutive year, the UCSF School of Pharmacy has received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

School researchers were awarded $29.2 million during the 2013 NIH fiscal year, from October 1, 2012 to...

UCSF team wins $2.7 million for innovative project to reduce premature births

A research team including co-principal investigators Shuvo Roy, PhD, and Mozziyar Etemadi, PhD, who trained in Roy’s lab, has been awarded a three-year $2.7 million grant from the Bill and Melinda Gates Foundation to further develop a remote monitoring and early warning system to reduce premature...

Pages